Siemens Healthineers (OTCMKTS:SMMNY – Get Free Report) announced its quarterly earnings results on Thursday. The company reported $0.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.02, Zacks reports. The company had revenue of $6.68 billion during the quarter, compared to analysts’ expectations of $6.96 billion.
Siemens Healthineers Price Performance
Shares of SMMNY stock traded down $0.07 during trading hours on Friday, reaching $19.84. The company had a trading volume of 147,758 shares, compared to its average volume of 169,811. The stock has a fifty day moving average of $21.90 and a 200-day moving average of $24.41. Siemens Healthineers has a 12-month low of $19.54 and a 12-month high of $28.92.
Analyst Ratings Changes
A number of analysts have recently weighed in on the company. Sanford C. Bernstein raised Siemens Healthineers to a “strong-buy” rating in a research report on Tuesday, January 13th. Citigroup reissued a “buy” rating on shares of Siemens Healthineers in a report on Friday, January 23rd. Finally, Zacks Research upgraded Siemens Healthineers from a “strong sell” rating to a “hold” rating in a research note on Monday, January 12th. Two research analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy”.
About Siemens Healthineers
Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.
The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.
Further Reading
Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.
